↓ Skip to main content

A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

Overview of attention for article published in Trials, December 2020
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
208 Mendeley
Title
A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study
Published in
Trials, December 2020
DOI 10.1186/s13063-020-04878-y
Pubmed ID
Authors

T. Vanassche, M. M. Engelen, Q. Van Thillo, J. Wauters, J. Gunst, C. Wouters, C. Vandenbriele, S. Rex, L. Liesenborghs, A. Wilmer, P. Meersseman, G. Van den Berghe, D. Dauwe, G. Verbeke, M. Thomeer, T. Fivez, D. Mesotten, D. Ruttens, L. Heytens, I. Dapper, S. Tuyls, B. De Tavernier, P. Verhamme

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 208 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 208 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 29 14%
Student > Master 20 10%
Researcher 16 8%
Other 14 7%
Student > Postgraduate 8 4%
Other 19 9%
Unknown 102 49%
Readers by discipline Count As %
Medicine and Dentistry 47 23%
Nursing and Health Professions 22 11%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Social Sciences 4 2%
Agricultural and Biological Sciences 3 1%
Other 19 9%
Unknown 105 50%